Otsuka, ICU Medical Launch Joint Venture in North America

MT Newswires Live11-14 07:28

Otsuka (TYO:4578) unit Otsuka Pharmaceutical Factory and ICU Medical have formed a joint venture with Otsuka Pharmaceutical Factory's US subsidiary, according to a Wednesday filing on the Tokyo Stock Exchange.

Under the JV, Otsuka Pharmaceutical Factory America will own a 60% stake in the newly established company.

The venture, set to begin operations in Q2 2025, will focus on IV solutions and clinical nutrition products in North America, amid ongoing shortages.

ICU Medical will transfer its IV business to the new company.

Price (JPY): $9110.00, Change: $-230, Percent Change: -2.47%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2483211861?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-14 07:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2483211861","market":"sg","top_or_hot":-1,"title":"Otsuka, ICU Medical Launch Joint Venture in North America","media":"MT Newswires Live","content":"<html><body><p> Otsuka (TYO:4578) unit Otsuka Pharmaceutical Factory and ICU Medical have formed a joint venture with Otsuka Pharmaceutical Factory's US subsidiary, according to a Wednesday filing on the Tokyo Stock Exchange.</p><p>Under the JV,  Otsuka Pharmaceutical Factory America will own a 60% stake in the newly established company.</p><p>The venture, set to begin operations in Q2 2025, will focus on IV solutions and clinical nutrition products in North America, amid ongoing shortages.</p><p>ICU Medical will transfer its IV business to the new company.</p><p>Price (JPY): $9110.00, Change: $-230, Percent Change: -2.47%</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Otsuka, ICU Medical Launch Joint Venture in North America</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOtsuka, ICU Medical Launch Joint Venture in North America\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-14 07:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Otsuka (TYO:4578) unit Otsuka Pharmaceutical Factory and ICU Medical have formed a joint venture with Otsuka Pharmaceutical Factory's US subsidiary, according to a Wednesday filing on the Tokyo Stock ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0106261612.USD","symbol_name":"SCHRODER ISF US SMALLER COMPANIES IMPACT \"A\" ACC","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2483211861","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2483211861","pubTimestamp":1731540530,"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Otsuka  unit Otsuka Pharmaceutical Factory and ICU Medical have formed a joint venture with Otsuka Pharmaceutical Factory's US subsidiary, according to a Wednesday filing on the Tokyo Stock Exchange.Under the JV,  Otsuka Pharmaceutical Factory America will own a 60% stake in the newly established company.The venture, set to begin operations in Q2 2025, will focus on IV solutions and clinical nutrition products in North America, amid ongoing shortages.ICU Medical will transfer its IV business to the new company.Price : $9110.00, Change: $-230, Percent Change: -2.47%","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0106261612.USD":"SCHRODER ISF US SMALLER COMPANIES IMPACT \"A\" ACC","LU0205194284.USD":"SCHRODER ISF US SMALL & MID-CAP EQUITY \"A\" (USD) INC AV","BK4185":"保健护理机构","LU0205193047.USD":"SCHRODER ISF US SMALL & MID-CAP EQUITY \"A\" (USD)  ACC","SG9999015945.SGD":"LionGlobal Disruptive Innovation Fund A SGD","LU0240878834.USD":"SCHRODER ISF GLOBAL SMALL COMPANIES \"A\" (USD) INC AV","LU0012050646.USD":"SCHRODER ISF US SMALLER COMPANIES IMPACT \"A\" (USD) INC AV","BK4198":"医疗保健用品","ICU":"SeaStar Medical Holding Corporation","LU0240877869.USD":"SCHRODER ISF GLOBAL SMALL COMPANIES \"A\" ACC","SG9999015986.USD":"LIONGLOBAL DISRUPTIVE INNOVATION \"I\" (USD) ACC","BK4082":"医疗保健设备","SG9999015978.USD":"利安颠覆性创新基金A","SG9999015952.SGD":"LIONGLOBAL DISRUPTIVE INNOVATION \"I\" (SGD) ACC","JYNT":"The Joint Corp.","ICUI":"ICU医疗"},"translate_title":"大冢与ICU Medical在北美成立合资企业","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ICU":1,"ICUI":1,"JYNT":1},"content_text":"Otsuka (TYO:4578) unit Otsuka Pharmaceutical Factory and ICU Medical have formed a joint venture with Otsuka Pharmaceutical Factory's US subsidiary, according to a Wednesday filing on the Tokyo Stock Exchange.Under the JV,  Otsuka Pharmaceutical Factory America will own a 60% stake in the newly established company.The venture, set to begin operations in Q2 2025, will focus on IV solutions and clinical nutrition products in North America, amid ongoing shortages.ICU Medical will transfer its IV business to the new company.Price (JPY): $9110.00, Change: $-230, Percent Change: -2.47%","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"Company Corporation","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2483211861"}